Account Info
Log Out
English
Back
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record delete
    Quotes All >
      News All >
        Log in to access Online Inquiry
        Watchlist
        Loading...
        US Stock MarketDetailed Quotes
        ABBV AbbVie Watchlist
        135.430 -1.430-1.04% Close 06/06 16:00 ET
        135.440+0.010+0.01% Post 19:29 ET
        137.540High134.630Low4.36MVolume
        Post-Market
        • 5D
        • 1D
        • 1W
        • 1M
        • 1Q
        • 1Y

        Company

        AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

        Revenue Breakdown

        Business Unit:USD
        NameYOYOperating income%
        HUMIRA--21.24B36.58%
        other--11.04B19.02%
        SKYRIZI--5.17B8.90%
        IMBRUVICA--4.57B7.87%
        All other--4.14B7.13%
        Botox Therapeutic--2.72B4.68%
        Botox Cosmetic--2.62B4.50%
        RINVOQ--2.52B4.34%
        Vraylar--2.04B3.51%
        VENCLEXTA--2.01B3.46%
        View all
        Paper Trade Start
        Symbol
        Direction
        Buy
        Sell
        Types
        LMT Order
        Price
        QTY
        Amount
        --